Start-Up Stadium Wednesday Afternoon
Wednesday, June 05, 2024
5B
Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology partnering event. During the 2024 BIO International Convention select finalists from around the world will share a quick pitch showcasing new technologies and therapeutic solutions to a panel of investor judges, followed by live feedback.
This year will also feature evaluation of the presentations from seed-stage company finalists (less than $1M raised) separate from emerging company finalists (more than $1M but less than $10M raised to date). with a winner identified for each category. Past prizes have included 'fast-track' admission review to incubator programs at the Illumina Accelerator and The Innovation Space, as well as complimentary, one-year memberships in the Biotechnology Innovation Organization with access to the cost-savings programs of BIO Business Solutions.
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
2:00 PM – 4:00 PM
(PST)
-
AcroCyte Therapeutics is a cell-based precision medicine company. Our current focus lies in utilizing our core technology R3CE—rapid, reproducible, rare cell expansion— to assist clinical treatment and scientific research.Start-Up Stadium Session
- Tools/Drug Development Support Tech
-
AgenT is a French life sciences company on a mission to defeat Alzheimer's by targeting the silent phase.Start-Up Stadium Session
- CNS/Neurological
-
GelSana's novel polymers improve healing in impaired wounds, particularly in chronic wounds with high inflammation.Start-Up Stadium Session
- Inflammation
-
Incircular's mission is to advance Biotech and Pharma applications by effective stabilization of proteins using INCYPRO, a cutting-edge chemical protein engineering technology.Start-Up Stadium Session
- Tools/Drug Development Support Tech
-
Keliomics is an emerging biotechnology company whose breakthrough platform for organ-scale biology preserves the full composition, structure, and function of primary human tissues.Start-Up Stadium Session
- Tools/Drug Development Support Tech
-
Longieva has been developing novel therapeutics for validated targets for CNS disorders with utility in neurodegeneration (such as Alzheimer's and Parkinson's) and addictive disorders.Start-Up Stadium Session
- CNS/Neurological
-
Founded in 2018 and headquartered in Derio (Bizkaia), Mikrobiomik is a bio-pharmaceutical company created to conduct research, develop and manufacture of medicines based on the human microbiome.Start-Up Stadium Session
- Platform for Therapeutics
-
Neuroene is developing mitochondrial-protective small molecules for epilepsy, Parkinson's and mitochondrial diseases.Start-Up Stadium Session
- CNS/Neurological
-
Orlia provides optimization tools to maximize yield and improve cell health and viability in bioreactors and fermenters.Start-Up Stadium Session
- Tools/Drug Development Support Tech
-
SiNON has developed a patented tunable carbon nanoparticle that acts as a ‘Trojan horse' drug delivery platform that allows drugs to cross the blood brain barrier to treat many different neurological diseases.Start-Up Stadium Session
- CNS/Neurological
-
VoxCell is creating human-like vascularized tissue models as a screening platform in drug development; by combining Canada's first high-resolution 3D bioprinter, VoxCell's proprietary universal bioinks and VoxCell's vascularization software.Start-Up Stadium Session
- Tools/Drug Development Support Tech